Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-PL-7, anti-Ro/SSA, anti-Mi-2, and anti-TIF1-γ correlate with specific patterns of histopathologic features in dermatomyositis: An analysis of 39 skin biopsy specimens from 25 patients.
Bennett R, Bradley K, Stevanovic M, McFadden JR, Chaudhari AS, Ramos-Rodriguez AJ, Yan S, Momtahen S, LeBlanc RE, Cloutier JM, Salem I, Grand DG, Hodson EL, Sriharan A. Bennett R, et al. J Cutan Pathol. 2024 Apr;51(4):317-326. doi: 10.1111/cup.14578. Epub 2023 Dec 29. J Cutan Pathol. 2024. PMID: 38158735
Cutaneous breast cancer of unknown primary.
Salem I, Bennett R, Hodson EL, Duprat GE, Doughty H, Georgantzoglou N, Linos K, Chamberlin MD, Chapman MS. Salem I, et al. Among authors: bennett r. JAAD Case Rep. 2023 Apr 6;37:45-48. doi: 10.1016/j.jdcr.2023.03.013. eCollection 2023 Jul. JAAD Case Rep. 2023. PMID: 37324179 Free PMC article. No abstract available.
Chronic urticaria after Moderna COVID-19 vaccine boosters: A case series.
Ryan C, Li K, Bennett R, Davis MJ, Shaker M, Hsu Blatman K, Hughes S, Mann JA. Ryan C, et al. Among authors: bennett r. JAAD Case Rep. 2024 Jan 23;45:27-30. doi: 10.1016/j.jdcr.2023.11.037. eCollection 2024 Mar. JAAD Case Rep. 2024. PMID: 38379871 Free PMC article. No abstract available.
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Benatar M, Hansen T, Rom D, Geist MA, Blaettler T, Camu W, Kuzma-Kozakiewicz M, van den Berg LH, Morales RJ, Chio A, Andersen PM, Pradat PF, Lange D, Van Damme P, Mora G, Grudniak M, Elliott M, Petri S, Olney N, Ladha S, Goyal NA, Meyer T, Hanna MG, Quinn C, Genge A, Zinman L, Jabari D, Shoesmith C, Ludolph AC, Neuwirth C, Nations S, Shefner JM, Turner MR, Wuu J, Bennett R, Dang H, Sundgreen C; ORARIALS-01 trial team. Benatar M, et al. Among authors: bennett r. Lancet Neurol. 2024 May 20:S1474-4422(24)00134-0. doi: 10.1016/S1474-4422(24)00134-0. Online ahead of print. Lancet Neurol. 2024. PMID: 38782015
2,443 results